Imidex Hires Wes Bolsen As CEO To Commercialize FDA-Cleared Artificial Intelligence Device For Lung Nodule And Mass Detection, Indicative Of Potential Early-Stage Lung Cancer

Imidex Hires Wes Bolsen As CEO To Commercialize FDA-Cleared Artificial Intelligence Device For Lung Nodule And Mass Detection, Indicative Of Potential Early-Stage Lung Cancer

(MENAFN - GlobeNewsWire - Nasdaq) Company is evaluating strategic partners and potential acquirers who could potentially treat 50% more lung nodule patients in the U.S. and save billions of dollars ...

ONLY AVAILABLE IN PAID PLANS

Published by: menafn

Read full article here: https://menafn.com/1108054151/Imidex-Hires-Wes-Bolsen-As-CEO-To-Commercialize-FDA-Cleared-Artificial-Intelligence-Device-For-Lung-Nodule-And-Mass-Detection-Indicative-Of-Potential-Early-Stage-Lung-Can

  • [email protected] (Menafn)
  • Top
  • Canada
  • Colombia
  • Dominican Republic
  • Ecuador
  • Uruguay
  • Cayman Islands
  • Jamaica
  • Argentina
  • Paraguay
  • Bahamas
  • Costa Rica
  • Netherland
  • Barbados
  • United States Of America
  • Haiti
  • Puerto Rico
  • Suriname
  • Chile
  • Grenada
  • Brazil
  • Bolivia
  • Honduras
  • Belize
  • Mexico
  • Venezuela
  • Peru
  • Guatemala
  • Panama
  • Nicaragua
  • El Salvador
  • Cuba
  • Guyana
Primedice

© BitNe. All Rights Reserved. Designed by HTML Codex

>